drugset / Trial / NCT03773042
A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients
Non-randomizedSequentialOpen-labelTreatment
Summary
A double-blind, randomized, active controlled, multi-center, parallel group study comparing HSK3486 with Propofol, in patients undergoing a colonoscopy.
Timeline
- Start
- 2016-12
- Primary completion
- 2017-06
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipepofol | Small molecule | 0.1 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.2 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.3 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.4 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.5 mg/kg | — |
| Comparator | Propofol | Small molecule | 1 mg/kg | — |
| Comparator | Propofol | Small molecule | 2 mg/kg | — |
Indications
No indication recorded.